UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, ~~D.C.~~ DC 20549

_______________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

_______________

Date of Report: March ~~February 11~~25, 2026

(Date of earliest event reported)

_______________

TENET HEALTHCARE CORPORATION

(Exact name of ~~registrant~~Registrant as specified in its charter)

Nevada

1-7293

95-2557091

(State of Incorporation)

(Commission File Number)

(IRS Employer
Identification Number)

14201 Dallas Parkway

Dallas, TX 75254

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of each exchange
on which registered

Common stock, $0.05 par value

THC

NYSE

6.875% Senior Notes due 2031

THC31

NYSE

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards ~~provided~~ pursuant to Section 13(a) of the Exchange Act. ☐ ☐

Item 25.02. ~~Results~~Departure of ~~Operations~~Directors ~~and~~or ~~Financial~~Certain ~~Condition~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

~~The~~Tenet ~~information~~Healthcare ~~contained~~Corporation ~~herein~~(the is“Company”) ~~being~~previously ~~furnished~~disclosed ~~pursuant~~that toits ~~Item~~Senior ~~2.02~~Vice ofPresident ~~Form~~& ~~8-K,~~Controller ~~“Results~~(Principal ofAccounting ~~Operations~~Officer), ~~and Financial Condition~~R.” ~~This~~Scott ~~information~~Ramsey, ~~shall~~provided ~~not~~notice beof ~~deemed~~his ~~“filed”~~plan ~~for~~to ~~purposes~~retire ofeffective ~~Section~~March 1831, of2026. The ~~the~~effective ~~Securities~~date ~~Exchange~~of ~~Act~~Mr. ofRamsey’s ~~1934~~retirement ~~(the~~has ~~“Exchange~~been ~~Act”),~~changed orto ~~incorporated~~April 30, by2026. ~~reference~~Mr. Ramsey inwill ~~any~~remain ~~filing~~employed ~~under~~on ~~the~~a ~~Securities~~part-time ~~Act~~basis ofthrough ~~1933~~March 31, ~~or the Exchange Act~~2028, ~~except~~for ascontinuing ~~shall~~transition beservices ~~expressly~~and ~~set forth by specific reference in such a filing~~support.

On ~~February~~March 1125, 2026, ~~Tenet~~the ~~Healthcare~~Company ~~Corporation~~appointed ~~(the~~J. ~~“Company”)~~Michael ~~issued~~Grooms, aage ~~press~~48, ~~release~~Senior ~~reporting~~Vice ~~the~~President ~~financial~~& ~~results~~Controller of the Company, ~~for~~effective ~~the quarter ended December~~April 316, ~~2025~~ 2026. AMr. ~~copy~~Grooms ofwill ~~the~~succeed ~~press~~Mr. ~~release~~Ramsey isas ~~attached~~the toCompany’s ~~this~~Principal ~~report~~Accounting asOfficer ~~Exhibit~~effective ~~99.~~May 1, ~~and~~2026, ~~incorporated~~following ~~herein~~the byeffective ~~reference~~date of Mr. Ramsey’s retirement.

Mr. Grooms has served as Senior Vice President, Chief Accounting Officer for Lifepoint Health, Inc. (“Lifepoint”), a healthcare provider that serves patients, clinicians, communities and partner organizations across the healthcare continuum, since 2018. Between 2006 and 2018, Mr. Grooms held various other reporting and accounting leadership roles of increasing responsibility at Lifepoint. Mr. Grooms began his career in public accounting as an auditor with KPMG.

Pursuant to the terms of Mr. Grooms’ offer letter with the Company, he will receive (i) an annual base salary of $475,000, (ii) a target cash bonus award at 60% of his salary, and (iii) an initial grant of Company restricted stock units (“RSUs”) with an approximate grant date value of $500,000 that vests one-half on the second anniversary of the grant date and the other half on the third anniversary of the grant date, and be recommended for a 2027 equity-based award with an approximate grant date value of $350,000, comprised of a combination of 50% service-based RSUs and 50% performance-based RSUs. Mr. Grooms will also receive a cash sign-on bonus of $250,000 and relocation benefits as described in the offer letter. For more information regarding the Company’s annual bonus and stock incentive award programs, see the Company’s Definitive Proxy Statement for the 2025 Annual Meeting of Shareholders filed with the Securities and Exchange Commission on April 11, 2025.


Item 9.01.			Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.	~~Description~~	Description
99.1	Press Release issued on February 11, 2026
104		Cover Page Interactive Data File (embedded within the inline XBRL document)
104	Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~Registrant~~registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		TENET HEALTHCARE CORPORATION
Date: February 11, 2026	By:	/s/ R. SCOTT RAMSEY
Date: March 30, 2026	By:	/s/ THOMAS ARNST
		R. Scott Ramsey
		Thomas Arnst
		Senior Vice President, Controller
		Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary

Filing Compare · TENET HEALTHCARE CORP